<table id="table6" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6: Clarithromycin Susceptibility Test Results and Clinical/Bacteriological Outcomes<footnote>Includes only patients with pretreatment clarithromycin susceptibility test results</footnote>
</caption>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="10%"></col>
<col align="center" valign="top" width="22%"></col>
<col align="center" valign="top" width="12%"></col>
<col align="center" valign="top" width="12%"></col>
<col align="center" valign="top" width="12%"></col>
<col align="center" valign="top" width="12%"></col>
<thead>
<tr stylecode="Botrule">
<th colspan="2" stylecode="Lrule Rrule">Clarithromycin Pretreatment Results</th>
<th colspan="5" stylecode="Rrule">Clarithromycin Post-treatment Results</th>
</tr>
<tr>
<th colspan="2" stylecode="Lrule Rrule"></th>
<th stylecode="Rrule">
<content stylecode="italics">H. pylori</content> negative - eradicated</th>
<th colspan="4" stylecode="Botrule Rrule">
<content stylecode="italics">H. pylori</content> positive – not eradicated<br/>Post-treatment susceptibility results</th>
</tr>
<tr>
<th stylecode="Lrule"></th>
<th stylecode="Rrule"></th>
<th stylecode="Rrule"></th>
<th stylecode="Rrule">S<footnote id="t6ft2">Susceptible (S) MIC ≤0.25 mcg/mL, Intermediate (I) MIC 0.5 to 1.0 mcg/mL, Resistant (R) MIC ≥2 mcg/mL</footnote>
</th>
<th stylecode="Rrule">I<footnoteref idref="t6ft2"></footnoteref>
</th>
<th stylecode="Rrule">R<footnoteref idref="t6ft2"></footnoteref>
</th>
<th stylecode="Rrule">No MIC</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td align="left" colspan="7" stylecode="Lrule Rrule">Triple Therapy 14-Day (lansoprazole 30 mg twice daily/amoxicillin 1 g twice daily/clarithromycin 500 mg twice daily)<br/> (M95-399, M93-131, M95-392)</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule">Susceptible<footnoteref idref="t6ft2"></footnoteref>
</td>
<td stylecode="Rrule">112</td>
<td stylecode="Rrule Botrule">105</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">7</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule Toprule">Intermediate<footnoteref idref="t6ft2"></footnoteref>
</td>
<td stylecode="Rrule Toprule">3</td>
<td stylecode="Rrule">3</td>
<td stylecode="Toprule Rrule"></td>
<td stylecode="Toprule Rrule"></td>
<td stylecode="Toprule Rrule"></td>
<td stylecode="Rrule Toprule"></td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule">Resistant<footnoteref idref="t6ft2"></footnoteref>
</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">6</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">7</td>
<td stylecode="Rrule">4</td>
</tr>
<tr stylecode="Botrule">
<td align="left" colspan="7" stylecode="Lrule Rrule">Triple Therapy 10-Day (lansoprazole 30 mg twice daily/amoxicillin 1 g twice daily/clarithromycin 500 mg twice daily) <br/> (M95-399)</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule">Susceptible<footnoteref idref="t6ft2"></footnoteref>
</td>
<td stylecode="Rrule">42</td>
<td stylecode="Rrule">40</td>
<td stylecode="Rrule">1</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">1</td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule">Intermediate<footnoteref idref="t6ft2"></footnoteref>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule">Resistant<footnoteref idref="t6ft2"></footnoteref>
</td>
<td stylecode="Rrule">4</td>
<td stylecode="Rrule">1</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">3</td>
<td stylecode="Rrule"></td>
</tr>
</tbody>
</table>